The Annals Evolution of Clinical Pharmacy | Now Available
home help contact us subscription past issues search current issue
 QUICK SEARCH:   [advanced]


     



Published Online, 14 August 2007, www.theannals.com, DOI 10.1345/aph.1H678.
The Annals of Pharmacotherapy: Vol. 41, No. 9, pp. 1390-1396. DOI 10.1345/aph.1H678
© 2007 Harvey Whitney Books Company.
This Article
Right arrow Résumé Freely available
Right arrow Extracto Freely available
Right arrow Full Text
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Omrane, R.
Right arrow Articles by Moride, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Omrane, R.
Right arrow Articles by Moride, Y.

CRITICAL CARE

Impact of a Protocol for Prevention of Ventilator-Associated Pneumonia

Rajae Omrane, BPharm MSc

Pharmacist, McGill University Health Center, Montreal, Québec, Canada

Jihane Eid, BPharm MSc

Pharmacist, McGill University Health Center

Marc M Perreault, PharmD BCPS

Critical Care Specialist and Clinical Associate Professor, Faculty of Pharmacy, Université de Montréal and McGill University Health Center

Hala Yazbeck, BPharm MSc

Critical Care Pharmacist, McGill University Health Center

Djamal Berbiche, PhD

Faculty of Pharmacy, Université de Montréal

Ashvini Gursahaney, MD FRCP(C)

ICU Director, Montreal General Site, McGill University Health Center

Yola Moride, PhD FISPE

Faculty of Pharmacy, Université de Montréal

Reprints: Mrs. Omrane, 3921 Joachim du Bellay, Laval, Québec, H7P 0A2, Canada, rajae.omrane{at}umontreal.ca

BACKGROUND: Several interventions have been shown to be effective in reducing the incidence of ventilator-associated pneumonia (VAP), but their implementation in clinical practice has not gained widespread acceptance.

OBJECTIVE: To determine the impact of a protocol that incorporates evidence-based interventions shown to reduce the frequency of VAP on the overall rate of VAP, early-onset VAP, and late-onset VAP in the intensive care unit (ICU) of a tertiary care adult teaching hospital.

METHODS: This pre- and postintervention observational study included mechanically ventilated patients admitted to the Montreal General Hospital ICU between November 2003 and May 2004 (preintervention) and between November 2004 and May 2005 (postintervention). A multidisciplinary prevention protocol was developed, implemented, and reinforced. Rates of VAP per 1000 ventilator-days were calculated pre- and postprotocol implementation for all patients, for patients with early-onset VAP, and for those with late-onset VAP.

RESULTS: In the pre- and postintervention groups, 349 and 360 patients, respectively, were mechanically ventilated. Twenty-three VAP episodes occurred in 925 ventilator-days (crude incidence rate 25 per 1000) in the preintervention period. Following implementation, the VAP rate decreased to 22 episodes in 988 ventilator-days (crude incidence rate 22.3 per 1000), corresponding to a relative reduction in rate of 10.8% (p < 0.001). The incidence of early-onset VAP decreased from 31.0 to 18.5 VAP per 1000 ventilator-days (p < 0.001), while the incidence of late-onset VAP increased from 21.9 to 24.1 VAP per 1000 ventilator-days (p < 0.001). However, when all covariates were adjusted, the impact of the prevention protocol was not statistically significant.

CONCLUSIONS: Implementation of a VAP prevention protocol incorporating evidence-based interventions reduced the crude incidence of VAP, early-onset VAP, and late-onset VAP. However, when covariates were adjusted, the beneficial effect was no longer observed. Further research is needed to assess the impact of such measures on VAP, early-onset VAP, and late-onset VAP.

Key Words: prevention, protocol, ventilator-associated pneumonia

Published Online, August 14, 2007. www.theannals.com, DOI 10.1345/aph.1H678


This article has been cited by other articles:


Home page
Arch SurgHome page
V. Zaydfudim, L. A. Dossett, J. M. Starmer, P. G. Arbogast, I. D. Feurer, W. A. Ray, A. K. May, and C. W. Pinson
Implementation of a Real-time Compliance Dashboard to Help Reduce SICU Ventilator-Associated Pneumonia With the Ventilator Bundle
Arch Surg, July 1, 2009; 144(7): 656 - 662.
[Abstract] [Full Text] [PDF]




homecopy help contact us subscription past issues search current issue
Copyright © 2007 by Harvey Whitney Books Company.